Advisory Services Network’s VanEck Pharmaceutical ETF PPH Stock Holding History

Advisory Services Network’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$2.81K	–	3992
2026 Q1	$2.81K	Buy	+27	New	+$2.88K	﹤0.01%	4043
2025 Q4	–	Sell	-457	Closed	-$41.3K	–	3621
2025 Q3	$41.3K	Buy	+457	New	+$40K	﹤0.01%	2555
2024 Q1	–	Sell	-110	Closed	-$8.95K	–	3088
2023 Q4	$8.95K	Buy	+110	New	+$8.63K	﹤0.01%	2906
2023 Q2	–	Sell	-90	Closed	-$6.99K	–	3070
2023 Q1	$6.99K	Hold	90	–	–	﹤0.01%	3016
2022 Q4	$7K	Buy	+90	New	+$6.64K	﹤0.01%	3006
2021 Q3	–	Sell	-1,636	Closed	-$120K	–	2751
2021 Q2	$120K	Buy	+1,636	New	+$117K	﹤0.01%	1510
2021 Q1	–	Sell	-1,275	Closed	-$85K	–	2531
2020 Q4	$85K	Buy	1,275 +385	+43%	+$24.7K	﹤0.01%	1399
2020 Q3	$55K	Buy	+890	New	+$56.3K	﹤0.01%	1543
2020 Q2	–	Sell	-340	Closed	-$18K	–	2298
2020 Q1	$18K	Sell	340 -334	-50%	-$20.6K	﹤0.01%	1930
2019 Q4	$43K	Sell	674 -106	-14%	-$6.39K	﹤0.01%	1573
2019 Q3	$46K	Hold	780	–	–	﹤0.01%	1400
2019 Q2	$46K	Buy	780 +2	+0.3%	+$116	﹤0.01%	1398
2019 Q1	$47K	Buy	778 +1	+0.1%	+$59	﹤0.01%	1267
2018 Q4	$43K	Buy	777 +1	+0.1%	+$61	﹤0.01%	1203
2018 Q3	$50K	Hold	776	–	–	﹤0.01%	1230
2018 Q2	$48K	Buy	776 +4	+0.5%	+$232	﹤0.01%	1226
2018 Q1	$44K	Sell	772 -99	-11%	-$5.92K	﹤0.01%	1372
2017 Q4	$52K	Buy	871 +1	+0.1%	+$57	﹤0.01%	1249
2017 Q3	$50K	Buy	870 +1	+0.1%	+$57	0.01%	1102
2017 Q2	$51K	Buy	869 +3	+0.3%	+$170	0.01%	1045
2017 Q1	$48K	Buy	+866	New	+$47K	0.01%	1007
2016 Q3	$44K	Buy	764 +2	+0.3%	+$120	0.01%	902
2016 Q2	$45K	Buy	762 +3	+0.4%	+$175	0.01%	811
2016 Q1	$44K	Buy	759 +1	+0.1%	+$59	0.01%	701
2015 Q4	$50K	Buy	758 +1	+0.1%	+$65	0.02%	582
2015 Q3	$48K	Buy	757 +2	+0.3%	+$141	0.01%	540
2015 Q2	$54K	Buy	755 +2	+0.3%	+$144	0.02%	487
2015 Q1	$53K	Hold	753	–	–	0.01%	483
2014 Q4	$50K	Buy	+753	New	+$48K	0.02%	426
2014 Q1	–	Sell	-750	Closed	-$40K	–	656
2013 Q4	$40K	Buy	+750	New	+$38K	0.02%	345

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Advisory Services Network's PPH Position: Q2 2026 in Review

Advisory Services Network sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 27 shares — an estimated $2.81K sold.

Advisory Services Network first reported a position in PPH in Q4 2013 and held it in 30 quarters. The position peaked at $120K in Q2 2021. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Advisory Services Network reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 27 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.81K.
Advisory Services Network first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 30 quarters.
Advisory Services Network's VanEck Pharmaceutical ETF position peaked at $120K in Q2 2021.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.